id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-300963-1n1f8mf2	Gajendran, Mahesh	Inflammatory bowel disease amid the COVID-19 pandemic: impact, management strategies, and lessons learned	2020-10-12		.txt	text/plain	6681	350	46	Previous studies based on SARS-CoV-1 showed that the "cytokine storm" was strongly associated with viral sepsis, inflammation-induced lung injury, and acute respiratory distress syndrome (ARDS) [32, 34] . With regard to IBD-specific risk factors, it is speculated that patients on immunosuppressive agents, those with active IBD symptoms, malnutrition, and frequent visits to clinics or hospitals are at greater risk of acquiring SARS-CoV-2 infection [50] . The International Organization for the Study of Inflammatory Bowel Diseases (IOIBD) maintains a registry for reporting COVID-19 in IBD patients called SECURE-IBD registry. Hence, all the societies have recommended that patients continue their IBD medications to sustain remission, because the risk of disease flare-up outweighs the chance of contracting SARS-CoV-2 infection. The management strategy will depend on multiple factors, such as the patient's age, the severity of the COVID-19 infection, the clinical status of the IBD, and the presence of other comorbid conditions.	./cache/cord-300963-1n1f8mf2.txt	./txt/cord-300963-1n1f8mf2.txt